Revenio Group Oyj (HEL:REG1V)

Market Cap	665.07M
Revenue (ttm)	107.22M
Net Income (ttm)	18.10M
Shares Out	26.60M
EPS (ttm)	0.68
PE Ratio	36.96
Forward PE	28.32
Dividend	0.40 (1.60%)
Ex-Dividend Date	Apr 11, 2025

Volume	9,880
Average Volume	19,102
Open	25.10
Previous Close	25.00
Day's Range	24.60 - 25.15
52-Week Range	21.35 - 32.88
Beta	1.43
RSI	68.21
Earnings Date	Oct 30, 2025

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for mea...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 241
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: REG1V

Financial Performance

In 2024, Revenio Group Oyj's revenue was 103.82 million, an increase of 7.27% compared to the previous year's 96.79 million. Earnings were 18.50 million, a decrease of -3.20%.